Anti-NMDAR autoimmune encephalitis

Brain and Development

Volumn 36, Issue 8, 2014, Pages 645-652

  Miya, Kazushi ^a   Takahashi, Yukitoshi ^b   Mori, Hisashi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b SHIZUOKA INSTITUTE OF EPILEPSY AND NEUROLOGICAL DISORDERS   (Japan)

Author keywords

Autoantibody; Encephalitis; N Methyl d aspartate receptor

Indexed keywords

ACICLOVIR; C REACTIVE PROTEIN; CREATININE; DEXAMETHASONE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROLEPTIC AGENT; SEDATIVE AGENT; AUTOANTIBODY;

AMNESIA; ANTI NMDAR ENCEPHALITIS; ANTIBODY DETECTION; ANXIETY DISORDER; AUTOIMMUNE DISEASE; AUTOMATISM; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CHILD; COGNITION; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; CONFUSION; CORTICOSTEROID THERAPY; COUGHING; CREATININE BLOOD LEVEL; DIAGNOSTIC PROCEDURE; DIFFUSION WEIGHTED IMAGING; DISEASE ASSOCIATION; DISEASE COURSE; DRUG TREATMENT FAILURE; DYSKINESIA; EARLY INTERVENTION; ELECTROENCEPHALOGRAPHY; EMOTIONAL DISORDER; ENCEPHALITIS; FEMALE; FEVER; FLUID ATTENUATION INVERSION RECOVERY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; INFLAMMATION; INTERNALIZATION; INVOLUNTARY MOVEMENT; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MENTAL DISEASE; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MUSCLE RIGIDITY; NEUROIMAGING; NOSE FEEDING; NUCLEAR MAGNETIC RESONANCE IMAGING; OROFACIAL DYSKINESIA; OVARY TERATOMA; PLEOCYTOSIS; PROGNOSIS; PSYCHOSIS; REVIEW; SCHOOL CHILD; SEIZURE; SPEECH INTELLIGIBILITY; VIRUS ENCEPHALITIS; VOMITING; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; COMPLICATION; IMMUNOLOGY; MALE; PARANEOPLASTIC NEUROPATHY; PATHOLOGY; TERATOMA;

AUTOANTIBODIES; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; CHILD; ENCEPHALITIS; FEMALE; HUMANS; LIMBIC ENCEPHALITIS; MALE; RECEPTORS, N-METHYL-D-ASPARTATE; TERATOMA;

EID: 84904514961     PISSN: 03877604     EISSN: 18727131     Source Type: Journal    
DOI: 10.1016/j.braindev.2013.10.005     Document Type: Review

References (52)

1. Bliss T.V., Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 1993, 361:31-39.
2. Komuro H., Rakic P. Modulation of neuronal migration by NMDA receptors. Science 1993, 260:95-97.
3. Mori H., Mishina M. Structure and function of the NMDA receptor channel. Neuropharmacology 1995, 34:1219-1237.
4. Lancelot E., Beal M.F. Glutamate toxicity in chronic neurodegenerative disease. Prog Brain Res 1998, 116:331-347.
5. Gunduz-Bruce H. The acute effects of NMDA antagonism: from the rodent to the human brain. Brain Res Rev 2009, 60:279-286.
6. Coyle J.T., Tsai G., Goff D. Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia. Ann NY Acad Sci 2003, 1003:318-327.
7. Brierley J., Corsellis J., Hierons R., Nevin S. Subacute encephalitis of later adult life. Mainly affecting the linbic areas. Brain 1960, 83:357-368.
8. Newman N.J., Bell I.R., McKee A.C. Paraneoplastic limbic encephalitis: neuropsychiatric presentation. Biol Psychiatry 1990, 27:529-542.
9. Buckley C., Oger J., Clover L., Tuzun E., Carpenter K., Jackson M., et al. Potassium channel antibodies in two patients with reversible limbic encephalitis. Ann Neurol 2001, 50:73-78.
10. Irani S.R., Alexander S., Waters P., Kleopa K.A., Pettingill P., Zuliani L., et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain 2010, 133:2734-2748.
11. Takahashi Y., Mori H., Mishina M., Watanabe M., Fujiwara T., Shimomura J., et al. Autoantibodies to NMDA receptor in patients with chronic forms of epilepsia partialis continua. Neurology 2003, 61:891-896.
12. Dalmau J., Tuzun E., Wu H.Y., Masjuan J., Rossi J.E., Voloschin A., et al. Paraneoplastic anti-N-methyl-d-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007, 61:25-36.
13. Dale R.C., Irani S.R., Brilot F., Pillai S., Webster R., Gill D., et al. N-methyl-d-aspartate receptor antibodies in pediatric dyskinetic encephalitis lethargica. Ann Neurol 2009, 66:704-709.
14. Florance N.R., Davis R.L., Lam C., Szperka C., Zhou L., Ahmad S., et al. Anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol 2009, 66:11-18.
15. Pruss H., Dalmau J., Harms L., Holtje M., Ahnert-Hilger G., Borowski K., et al. Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin. Neurology 2010, 75:1735-1739.
16. Day G.S., High S.M., Cot B., Tang-Wai D.F. Anti-NMDA-receptor encephalitis: case report and literature review of an under-recognized condition. J Gen Intern Med 2011, 26:811-816.
17. Dalmau J., Gleichman A.J., Hughes E.G., Rossi J.E., Peng X., Lai M., et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008, 7:1091-1098.
18. Titulaer M.J., McCracken L., Gabilondo I., Armangué T., Glaser C., Iizuka T., et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 2013, 12:157-165.
19. Bien C.G., Vincent A., Barnett M.H., Becker A.J., Blumcke I., Graus F., et al. Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis. Brain 2012, 135:1622-1638.
20. Davis R., Dalmau J. Autoimmunity, seizures, and status epilepticus. Epilepsia 2013, 54:46-49.
21. Granerod J., Ambrose H.E., Davies N.W., Clewley J.P., Walsh A.L., Morgan D., et al. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis 2010, 10:835-844.
22. Irani S.R., Bera K., Waters P., Zuliani L., Maxwell S., Zandi M.S., et al. N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 2010, 133:1655-1667.
23. Gable M.S., Sheriff H., Dalmau J., Tilley D.H., Glaser C.A. The frequency of autoimmune N-methyl-d-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California encephalitis project. Clin Infect Dis 2012, 54:899-904.
24. Tsutsui K., Kanbayashi T., Tanaka K., Boku S., Ito W., Tokunaga J., et al. Anti-NMDA-receptor antibody detected in encephalitis, schizophrenia, and narcolepsy with psychotic features. BMC Psychiatry 2012, 12:37.
25. Steiner J., Walter M., Glanz W., Sarnyai Z., Bernstein H.G., Vielhaber S., et al. Increased prevalence of diverse N-methyl-d-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-d-aspartate glutamate receptor encephalitis. JAMA Psychiatry 2013, 70:271-278.
26. Barry H., Hardiman O., Healy D.G., Keogan M., Moroney J., Molnar P.P., et al. Anti-NMDA receptor encephalitis: an important differential diagnosis in psychosis. Br J Psychiatry 2011, 199:508-509.
27. Stepulak A., Luksch H., Gebhardt C., Uckermann O., Marzahn J., Sifringer M., et al. Expression of glutamate receptor subunits in human cancers. Histochem Cell Biol 2009, 132:435-445.
28. Li L., Hanahan D. Hijacking the neuronal NMDAR signaling circuit to promote tumor growth and invasion. Cell 2013, 153:86-100.
29. Prickett T.D., Samuels Y. Molecular pathways: dysregulated glutamatergic signaling pathways in cancer. Clin Cancer Res 2012, 18:4240-4246.
30. Armangue T., Titulaer M.J., Malaga I., Bataller L., Gabilondo I., Graus F., et al. Pediatric anti-N-methyl-d-aspartate receptor encephalitis - clinical analysis and novel findings in a series of 20 patients. J Pediatr 2013, 162:850-856.
31. Turner M.R., Irani S.R., Leite M.I., Nithi K., Vincent A., Ansorge O. Progressive encephalomyelitis with rigidity and myoclonus: glycine and NMDA receptor antibodies. Neurology 2011, 77:439-443.
32. Schmitt S.E., Pargeon K., Frechette E.S., Hirsch L.J., Dalmau J., Friedman D. Extreme delta brush: a unique EEG pattern in adults with anti-NMDA receptor encephalitis. Neurology 2012, 79:1094-1100.
33. Goldberg E.M., Taub K.S., Kessler S.K., Abend N.S. Anti-NMDA receptor encephalitis presenting with focal non-convulsive status epilepticus in a child. Neuropediatrics 2011, 42:188-190.
34. Kirkpatrick M.P., Clarke C.D., Sonmezturk H.H., Abou-Khalil B. Rhythmic delta activity represents a form of nonconvulsive status epilepticus in anti-NMDA receptor antibody encephalitis. Epilepsy Behav 2011, 20:392-394.
35. Morooka M., Kubota K., Minamimoto R., Furuhata M., Abe T., Ito K., et al. 18F-FDG and 11C-methionine PET/CT findings in a case with anti-NMDA (NR2B) receptor encephalitis. Clin Nucl Med 2012, 37:400-402.
36. Takano S., Takahashi Y., Kishi H., Taguchi Y., Takashima S., Tanaka K., et al. Detection of autoantibody against extracellular epitopes of N-methyl-d-aspartate receptor by cell-based assay. Neurosci Res 2011, 71:294-302.
37. Anegawa N.J., Lynch D.R., Verdoorn T.A., Pritchett D.B. Transfection of N-methyl-d-aspartate receptors in a nonneuronal cell line leads to cell death. J Neurochem 1995, 64:2004-2012.
38. Suh-Lailam B.B., Haven T.R., Copple S.S., Knapp D., Jaskowski T.D., Tebo A.E. Anti-NMDA-receptor antibody encephalitis: performance evaluation and laboratory experience with the anti-NMDA-receptor IgG assay. Clin Chim Acta 2013, 421:1-6.
39. Dalmau J., Lancaster E., Martinez-Hernandez E., Rosenfeld M.R., Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 2011, 10:63-74.
40. Pham H.P., Daniel-Johnson J.A., Stotler B.A., Stephens H., Schwartz J. Therapeutic plasma exchange for the treatment of anti-NMDA receptor encephalitis. J Clin Apher 2011, 26:320-325.
41. Ikeguchi R., Shibuya K., Akiyama S., Hino S., Kubo H., Takeda T., et al. Rituximab used successfully in the treatment of anti-NMDA receptor encephalitis. Intern Med 2012, 51:1585-1589.
42. Kashyape P., Taylor E., Ng J., Krishnakumar D., Kirkham F., Whitney A. Successful treatment of two paediatric cases of anti-NMDA receptor encephalitis with cyclophosphamide: the need for early aggressive immunotherapy in tumour negative paediatric patients. Eur J Paediatr Neurol 2012, 16:74-78.
43. Seki M., Suzuki S., Iizuka T., Shimizu T., Nihei Y., Suzuki N., et al. Neurological response to early removal of ovarian teratoma in anti-NMDAR encephalitis. J Neurol Neurosurg Psychiatry 2008, 79:324-326.
44. Leypoldt F., Gelderblom M., Schottle D., Hoffmann S., Wandinger K.P. Recovery from severe frontotemporal dysfunction at 3years after N-methyl-d-aspartic acid (NMDA) receptor antibody encephalitis. J Clin Neurosci 2013, 20:611-613.
45. Poloni C., Korff C.M., Ricotti V., King M.D., Perez E.R., Mayor-Dubois C., et al. Severe childhood encephalopathy with dyskinesia and prolonged cognitive disturbances: evidence for anti-N-methyl-d-aspartate receptor encephalitis. Dev Med Child Neurol 2010, 52:78-82.
46. Gabilondo I., Saiz A., Galan L., Gonzalez V., Jadraque R., Sabater L., et al. Analysis of relapses in anti-NMDAR encephalitis. Neurology 2011, 77:996-999.
47. Hughes E.G., Peng X., Gleichman A.J., Lai M., Zhou L., Tsou R., et al. Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci 2010, 30:5866-5875.
48. Xu C.L., Liu L., Zhao W.Q., Li J.M., Wang R.J., Wang S.H., et al. Anti-N-methyl-d-aspartate receptor encephalitis with serum anti-thyroid antibodies and IgM antibodies against Epstein-Barr virus viral capsid antigen: a case report and one year follow-up. BMC Neurol 2011, 11:149.
49. Martinez-Hernandez E., Horvath J., Shiloh-Malawsky Y., Sangha N., Martinez-Lage M., Dalmau J. Analysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis. Neurology 2011, 77:589-593.
50. Camdessanche J.P., Streichenberger N., Cavillon G., Rogemond V., Jousserand G., Honnorat J., et al. Brain immunohistopathological study in a patient with anti-NMDAR encephalitis. Eur J Neurol 2011, 18:929-931.
51. Dale R.C., Pillai S., Brilot F. Cerebrospinal fluid CD19(+) B-cell expansion in N-methyl-d-aspartate receptor encephalitis. Dev Med Child Neurol 2013, 55:191-193.
52. Mikasova L., De Rossi P., Bouchet D., Georges F., Rogemond V., Didelot A., et al. Disrupted surface cross-talk between NMDA and ephrin-B2 receptors in anti-NMDA encephalitis. Brain 2012, 135:1606-1621.